Correction: BMC Genomics 22, 518 (2021)
https://doi.org/10.1186/s12864-021-07660-9
Following publication of the original article [1], it was reported that Figs. 4, 5 and 6 were published out of order, though the captions were correct. The figures for Figs. 4, 5 and 6 were originally published as Figs. 5, 6 and 4 respectively.
The correct figures are given in this Correction article and the original article [1] has been updated.
Concerti fishplot and tumor evolution tree T for patient CLL1 multi-time data. The fishplot width corresponds to approximate tumor size using ALC (absolute lymphocyte count) values. Clones are colored and sized proportionally to their prevalence. The corresponding tumor tree is aligned by timepoint and highlights to the birth of brown clone, which occurred prior to the annotation of clinical relapse. Node sizes correspond to prevalence. The edges of the T are labeled by the known cancer genes and the colors denote the distinct pseudoclones estimated by Concerti. Red asterisks indicates acquisition of new alterations to clone
Concerti fishplot and tumor evolution tree T for patient CLL2 multi-time data. The fishplot width corresponds to approximate tumor size using ALC values. Clones are colored and sized proportionally to their prevalence. The corresponding tumor tree is aligned by timepoint and highlights to the birth of brown clone, which occurred prior to the annotation of clinical relapse. Node sizes correspond to prevalence. The edges of the T are labeled by the known cancer genes and the colors denote the distinct pseudoclones estimated by Concerti. Red asterisk indicates acquisition of new alterations to clone
Concerti tumor evolution tree T for patient GI1. Tumor evolution tree T for colon cancer patient GI1 multi-site data. The edges of the T are labeled by the known cancer genes and the colors denote the distinct pseudoclones estimated by Concerti. Leaf nodes represent each of the distinct lesion sites. The single site trees τ are shown at the bottom as stacked discs and the sizes are proportional to the prevalence values
Reference
Utro F, Levovitz C, Rhrissorrakrai K, et al. A common methodological phylogenomics framework for intra-patient heteroplasmies to infer SARS-CoV-2 sublineages and tumor clones. BMC Genomics. 2021;22(Suppl 5):518. https://doi.org/10.1186/s12864-021-07660-9.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Utro, F., Levovitz, C., Rhrissorrakrai, K. et al. Correction: A common methodological phylogenomics framework for intra-patient heteroplasmies to infer SARS-CoV-2 sublineages and tumor clones. BMC Genomics 24, 6 (2023). https://doi.org/10.1186/s12864-022-08959-x
Published:
DOI: https://doi.org/10.1186/s12864-022-08959-x